Published in Urology on March 01, 1984
DNA-flow cytometry of head and neck carcinoma: the importance of uniform tissue sampling and tumor sites. Eur Arch Otorhinolaryngol (1992) 0.75
Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer (1988) 1.30
NCCN Practice Guidelines for Prostate Cancer. Oncology (Williston Park) (2000) 1.19
Phase I clinical trial of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol (1987) 1.12
Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry (1984) 1.11
Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. Cytometry (1984) 0.99
Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res (1984) 0.99
Primary mediastinal germ cell tumors. Histologic patterns of treatment failures at autopsy. Cancer (1988) 0.93
A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days. Cancer Chemother Pharmacol (1989) 0.92
Results of surgical treatment of renal cell carcinoma with solitary metastasis. J Urol (1988) 0.90
Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Cancer Res (1985) 0.90
Chylous ascites and lymphocyst management by peritoneovenous shunt. Surgery (1991) 0.90
Protection of germinal epithelium with luteinizing hormone-releasing hormone analogue. J Urol (1985) 0.89
Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder. J Urol (1989) 0.89
Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer. Urology (1986) 0.89
Flow cytometric analysis of double-stranded RNA content distributions. J Histochem Cytochem (1980) 0.86
Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol (1984) 0.86
Prognostic factors in localized prostatic carcinoma. J Urol (1985) 0.86
Therapeutic embolization of pelvic metastases of renal cell carcinoma. J Urol (1984) 0.86
Prognostic applications of DNA flow cytometry for human solid tumors. Ann N Y Acad Sci (1986) 0.85
Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy. J Urol (1991) 0.84
Effect of hydrocortisone, adrenalin and actinomycin D on transition of cells to the DNA synthesis phase. Exp Cell Res (1968) 0.84
Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol (1994) 0.83
Transitional cell carcinoma in a solitary, giant hydronephrotic kidney. Br J Urol (1986) 0.83
Detection of DNA damage in individual cells by flow cytometric analysis using anti-DNA monoclonal antibody. Exp Cell Res (1987) 0.83
Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II. Cancer Res (1985) 0.81
Immediate postoperative feeding in urological surgery. J Urol (1984) 0.81
Management and prognostic significance of hypercalcemia in renal cell carcinoma. Urology (1989) 0.81
Mitotic cycle and cell differentiation in squamous cell carcinomas. Int J Cancer (1967) 0.81
Massive intrascrotal fibrolipoma. J Urol (1983) 0.81
Assessment of human genitourinary tumors and chemosensitivity testing in 3-dimensional collagen gel culture. J Urol (1990) 0.80
A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Genet Cytogenet (1993) 0.80
Effect of tumor promoters on cell kinetics in mouse epidermis. J Natl Cancer Inst (1972) 0.80
Increased uptake of vital dye Hoechst 33342 during S phase in synchronized HeLa S3 cells. Cytometry (1983) 0.79
Interferon-beta treatment of metastatic prostate cancer. J Surg Oncol (1986) 0.79
Prognostic factors in survival of bladder cancer. Cancer (1992) 0.78
Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids. Cancer (1985) 0.78
Involvement of chromosomes 3 and 5 in renal cell carcinoma. Cancer Genet Cytogenet (1988) 0.78
Intercellular adhesion in butyrate-treated HeLa S3 cultures. Flow cytometric analysis. Exp Cell Res (1982) 0.78
Cytogenetic findings in a primary adrenocortical carcinoma. Cancer Genet Cytogenet (1987) 0.78
Prostate cancer: an update. CA Cancer J Clin (1986) 0.77
[The effect of 4-methyl-2,6-di-tert.-butylphenol (ionol) on liver tumor induction in rats]. Biull Eksp Biol Med (1967) 0.77
Seminoma at Roswell Park, 1970 to 1979. An analysis of treatment failures. Cancer (1984) 0.77
Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol (1985) 0.77
Immunotherapy of a murine renal cancer. J Urol (1983) 0.77
Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J Urol (1985) 0.77
Effect of methotrexate on the cell cycle of L1210 leukemia. Cell Tissue Kinet (1976) 0.77
In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer. J Urol (1991) 0.77
Humoral immune response of patients receiving specific active immunotherapy for renal cell carcinoma. Cancer Res (1985) 0.76
Histological patterns of treatment failures in testicular neoplasms. J Urol (1985) 0.76
The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation. J Urol (1990) 0.76
Assessment of cell viability by flow cytometric analysis using DNase exclusion. Exp Cell Res (1983) 0.76
Unbalanced growth and cell death in HeLa S3 cultures treated with DNA synthesis inhibitors. J Cell Physiol (1981) 0.76
Cryosurgical ablation of the prostate. Urol Oncol (2011) 0.75
Transrectal ultrasonography of the prostate and prostate cancer--an update. Appl Pathol (1985) 0.75
Enhancement of the antitumor activity of 5-fluorouracil by drug combinations. Cancer Res (1973) 0.75
[Distribution of cells synthesizing DNA in hyperplastic epidermis and skin papillomas in mice]. Tsitologiia (1970) 0.75
[The effect of x-irradiation on the differentiation of epidermoid cancer cells in mice]. Vopr Onkol (1970) 0.75
[Autoradiographic studies of precancerous changes in the uterine cervix]. Vopr Onkol (1969) 0.75
Multilocular cyst of the kidney: a case report. J Surg Oncol (1984) 0.75
[Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210]. Tsitologiia (1975) 0.75
Resistance of stomach epithelium to cytotoxic effect of antitumor drugs. Increase of sensitivity by actinomycin D. Eur J Cancer (1977) 0.75
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma. Urology (1987) 0.75
[Decrease in the tissue-specific resistance of gastric epithelium to acute cell death following inhibition of DNA synthesis]. Biull Eksp Biol Med (1977) 0.75
[Mouse Lewis carcinoma cell population heterogeneity and sensitivity to cyclophosphamide]. Tsitologiia (1978) 0.75
Severely contracted bladder following intravesical mitomycin C therapy. J Urol (1983) 0.75
[Effect of cocarcinogens on cell kinetics in mouse epidermis]. Tsitologiia (1972) 0.75
Bleomycin-induced nodular pulmonary fibrosis masquerading as metastatic testicular cancer. J Urol (1986) 0.75
Treatment of advanced seminoma. Prog Clin Biol Res (1985) 0.75
[Effect of N-nitroso-N'-methylurea on the cellular kinetics in tumors]. Vopr Onkol (1977) 0.75
[Radioautographic studies of the cell life cycle in spontaneous tumors of mammary glands in mice at different intensities of proliferation]. Tsitologiia (1968) 0.75
[Effect of x-radiation on cell differentiation]. Tsitologiia (1970) 0.75
[Acute cell death in various sections of the gastrointestinal tract in DNA synthesis inhibition]. Biull Eksp Biol Med (1975) 0.75
The treatment of poor risk nonseminomatous testicular tumors. J Urol (1984) 0.75
Advances in the treatment of testicular tumors. Int Adv Surg Oncol (1984) 0.75
Epidermal chalone. Effect on cell cycle and on development of hyperplasia. Exp Cell Res (1971) 0.75
Aspiration biopsy of testis: another method for histologic examination. Fertil Steril (1984) 0.75
Secondary urinoma mimicking recurrent tumor as a cause of bilateral ureteral obstruction. J Surg Oncol (1987) 0.75
Clitoromegaly and megalourethra in idiopathic female intersex. J Urol (1981) 0.75
Fast onset of DNA synthesis stimulated by tumor promotor in mouse epidermis at the initation stage of carcinogenesis. J Natl Cancer Inst (1973) 0.75
Simple method for the management of hematuria caused by radiation or cytoxan. Eur Urol (1987) 0.75
Pelvic rhabdomyosarcoma: a review of the RPMI experience. Urology (1986) 0.75
[Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability]. Vopr Onkol (1975) 0.75
[Conference on cell cycles]. Tsitologiia (1970) 0.75
Early complications of combined pelvic lymphadenectomy and radical prostatectomy versus lymphadenectomy alone. Prostate (1986) 0.75
[Cellular cycle of transplantable leukemia L 1210]. Vopr Onkol (1973) 0.75
Stimulation of DNA synthesis in the mouse epidermis at the stage of initiation of carcinogenesis. Bull Exp Biol Med (1974) 0.75
Tumor markers in bladder cancer. Urology (1984) 0.75
Prostate metabolism of steroids following castration. Prog Clin Biol Res (1987) 0.75
[Autoradiography of tumors of the uterine cervix]. Vopr Onkol (1969) 0.75
[Tissue-specific inhibitors of cell division (chylons) in the epidermis. Effect on the cell cycle and development of hyperplasia]. Dokl Akad Nauk SSSR (1971) 0.75
The effect of nitrofurantoin on bladder tumor cell lines: in vitro growth and implantation in the cauterized mouse bladder. J Urol (1985) 0.75
Experimental photodynamic treatment of canine bladder. J Urol (1985) 0.75
Bladder reconstruction in the surgical management of bladder cancer. Cancer Invest (1984) 0.75
Vaginal recurrence after cystectomy for bladder cancer. J Urol (1985) 0.75
Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases. Urology (1984) 0.75
Growth of human urologic tumors on extracellular matrix. J Urol (1986) 0.75
The role of routine followup bone scans after definitive therapy of localized prostatic cancer. J Urol (1982) 0.75